Treatment With Lenvatinib to Anaplastic Thyroid Cancer :

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
doi 10.5106/jjshns.28.217
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Society for Head and Neck Surgery

Related search

Administration of Lenvatinib to Patients With Anaplastic Thyroid Cancer

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Lenvatinib as a Novel Treatment for Anaplastic Thyroid Cancer: A Retrospective Study

Oncology Letters
Cancer ResearchOncology
2018English

Lenvatinib vs. Palliative Therapy for Stage IVC Anaplastic Thyroid Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

Management of One Patient With Oligoprogressive Thyroid Cancer During Treatment With Lenvatinib

Future Oncology
MedicineCancer ResearchOncology
2019English

Optimal Use of Lenvatinib in the Treatment of Advanced Thyroid Cancer

Cancers of the Head & Neck
2017English

Treatment and Survival Vary by Race/Ethnicity in Patients With Anaplastic Thyroid Cancer

Cancer
Cancer ResearchOncology
2018English

Endometrioid Adenocarcinoma Metastatic to the Thyroid, Presenting Like Anaplastic Thyroid Cancer

Case Reports in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Unusual Manifestation of Anaplastic Thyroid Cancer

Acta medica (Hradec Kralove)
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy